{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:30:49Z","timestamp":1791462649388,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T00:00:00Z","timestamp":1423699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s00415-015-7664-0","type":"journal-article","created":{"date-parts":[[2015,2,11]],"date-time":"2015-02-11T06:09:34Z","timestamp":1423634974000},"page":"968-978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment"],"prefix":"10.1007","volume":"262","author":[{"given":"Federica","family":"Montagnese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Barca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mondello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Migliorato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ciranni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rodolico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"De Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Danesino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,12]]},"reference":[{"key":"7664_CR1","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/ajmg.a.36110","volume":"161A","author":"PS Kishnani","year":"2013","unstructured":"Kishnani PS, Amartino HM, Lindberg C, Miller TM, Wilson A, Keutzer J, On behalf of the Pompe Registry Boards of Advisors (2013) Timing of diagnosis of patients with Pompe disease: data from the Pompe Registry. Am J Med Genet Part A 161A:2431\u20132443","journal-title":"Am J Med Genet Part A"},{"key":"7664_CR2","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/jmg.32.10.836-a","volume":"32","author":"MA Kroos","year":"1995","unstructured":"Kroos MA, van der Kraan M, van Diggelen OP, Kleijer WJ, Reuser AJ, van den BooGAArd MJ, Ausems MG, van Ploos Amstel HK, Poenaru L, Nicolino M (1995) Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients. J Med Genet 32:836\u2013837","journal-title":"J Med Genet"},{"key":"7664_CR3","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1002\/mus.880181414","volume":"3","author":"AJJ Reuser","year":"1995","unstructured":"Reuser AJJ, Verheijen FW, Kroos MA et al (1995) Glycogenosis type II (acid maltase deficiency). Muscle Nerve 3:S61","journal-title":"Muscle Nerve"},{"issue":"6","key":"7664_CR4","first-page":"177","volume":"23","author":"JA Lim","year":"2014","unstructured":"Lim JA, Li L, Raben N (2014) Pompe disease: from pathophysiology to therapy and back again. Front Aging Neurosci. 23(6):177","journal-title":"Front Aging Neurosci."},{"key":"7664_CR5","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","volume":"372","author":"AT Ploeg Van der","year":"2008","unstructured":"Van der Ploeg AT, Reuser AJ (2008) Pompe\u2019s disease. Lancet 372:1342\u20131353","journal-title":"Lancet"},{"key":"7664_CR6","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1212\/WNL.55.8.1122","volume":"55","author":"P Laforet","year":"2000","unstructured":"Laforet P, Nicolino M, Eymard PB, Puech JP, Caillaud C, Poenaru L, Fardeau M (2000) Juvenile and adult-onset acid maltase deficiency in France: genotype phenotype correlation. Neurology 55:1122\u20131128","journal-title":"Neurology"},{"key":"7664_CR7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/humu.20374","volume":"27","author":"AL Montalvo","year":"2006","unstructured":"Montalvo AL, Bembi B, Donnarumma M, Filocamo M, Parenti G, Rossi M, Merlini L, Buratti E, De Filippi P, Dardis A et al (2006) Mutation profile of the GAA gene in 40 Italian patients with late onset glycogen storage disease type II. Hum Mutat 27:999\u20131006","journal-title":"Hum Mutat"},{"key":"7664_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1172-7-35","volume":"7","author":"A Herzog","year":"2012","unstructured":"Herzog A, Hartung R, Reuser A, Hermanns P, Runz H, Karabul N, G\u00f6kce S, Pohlenz J, Kampmann C, Lampe C, Beck M, Mengel E (2012) A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations. Orphanet J Rare Dis 7:35","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl 2","key":"7664_CR9","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.1007\/s10545-008-0820-2","volume":"31","author":"PR Joshi","year":"2008","unstructured":"Joshi PR, Gl\u00e4ser D, Schmidt S, Vorgerd M, Winterholler M, Eger K, Zierz S, Deschauer M (2008) Molecular diagnosis of\u00a0German\u00a0patients with late-onset glycogen storage disease type II. J Inherit Metab Dis 31(Suppl 2):S261\u2013S265","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"7664_CR10","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1002\/humu.20745","volume":"29","author":"M Kroos","year":"2008","unstructured":"Kroos M, Pomponio RJ, van Vliet L, Palmer RE, Phipps M, Van der Helm R, Halley D, Reuser AJ (2008) GAA Database Consortium. Update\u00a0of the\u00a0Pompe\u00a0disease mutation database with 107 sequence variants and a format for severity rating. Hum Mutat 29(6):E13\u2013E26","journal-title":"Hum Mutat"},{"issue":"1","key":"7664_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajmg.c.31318","volume":"160C","author":"M Kroos","year":"2012","unstructured":"Kroos M, Hoogeveen-Westerveld M, Van der Ploeg A, Reuser AJ (2012) The genotype phenotype correlation in Pompe disease. Am J Med Genet C Semin Med Genet 160C(1):59\u201368","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"2","key":"7664_CR12","first-page":"78","volume":"32","author":"A Toscano","year":"2013","unstructured":"Toscano A, Montagnese F, Musumeci O (2013) Early is better? A new algorithm for early diagnosis in late onset Pompe disease (LOPD). Acta Myol 32(2):78\u201381","journal-title":"Acta Myol"},{"issue":"11","key":"7664_CR13","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.nmd.2011.06.748","volume":"21","author":"RY Carlier","year":"2011","unstructured":"Carlier RY, Laforet P, Wary C, Mompoint D, Laloui K, Pellegrini N, Annane D, Carlier PG, Orlikowski D (2011) Whole-body muscle MRI in 20 patients suffering from late onset\u00a0Pompe\u00a0disease: involvement patterns. Neuromuscul Disord 21(11):791\u2013799","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"7664_CR14","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ymgme.2013.06.023","volume":"110","author":"M Gaeta","year":"2013","unstructured":"Gaeta M, Barca E, Ruggeri P, Minutoli F, Rodolico C, Mazziotti S, Milardi D, Musumeci O, Toscano A (2013) Late-onset\u00a0Pompe\u00a0disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function. Mol Genet Metab 110(3):290\u2013296","journal-title":"Mol Genet Metab"},{"issue":"15","key":"7664_CR15","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT Ploeg Van der","year":"2010","unstructured":"Van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, Herson S, Kishnani PS, Laforet P, Lake SL, Lange DJ, Leshner RT, Mayhew JE, Morgan C, Nozaki K, Park DJ, Pestronk A, Rosenbloom B, Skrinar A, van Capelle CI, van der Beek NA, Wasserstein M, Zivkovic SA (2010) A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease. N Engl J Med 362(15):1396\u20131406","journal-title":"N Engl J Med"},{"issue":"3","key":"7664_CR16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymgme.2012.09.015","volume":"107","author":"AT Ploeg Van der","year":"2012","unstructured":"Van der Ploeg AT, Barohn R, Carlson L, Charrow J, Clemens PR, Hopkin RJ, Kishnani PS, Lafor\u00eat P, Morgan C, Nations S, Pestronk A, Plotkin H, Rosenbloom BE, Sims KB, Tsao E (2012) Open-label extension study following the late-onset treatment study (LOTS) of alglucosidase alfa. Mol Genet Metab 107(3):456\u2013461","journal-title":"Mol Genet Metab"},{"issue":"1","key":"7664_CR17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00415-009-5275-3","volume":"257","author":"S Strothotte","year":"2010","unstructured":"Strothotte S, Strigl-Pill N, Grunert B, Kornblum C, Eger K, Wessig C, Deschauer M, Breunig F, Glocker FX, Vielhaber S, Brejova A, Hilz M, Reiners K, M\u00fcller-Felber W, Mengel E, Spranger M, Schoser B (2010) Enzyme\u00a0replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J Neurol 257(1):91\u201397","journal-title":"J Neurol"},{"issue":"5","key":"7664_CR18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00415-011-6293-5","volume":"259","author":"C Angelini","year":"2012","unstructured":"Angelini C, Semplicini C, Ravaglia S, Bembi B, Servidei S, Pegoraro E, Moggio M, Filosto M, Sette E, Crescimanno G, Tonin P, Parini R, Morandi L, Marrosu G, Greco G, Musumeci O, Di Iorio G, Siciliano G, Donati MA, Carubbi F, Ermani M, Mongini T, Toscano A, Italian GSDII Group (2012) Observational clinical study in juvenile-adult\u00a0glycogenosis\u00a0type 2 patients undergoing enzyme replacement therapy for up to 4\u00a0years. J Neurol 259(5):952\u2013958","journal-title":"J Neurol"},{"issue":"4","key":"7664_CR19","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","volume":"260","author":"A Toscano","year":"2013","unstructured":"Toscano A, Schoser B (2013) Enzyme\u00a0replacement therapy in late-onset Pompe disease: a systematic literature review. J Neurol 260(4):951\u2013959","journal-title":"J Neurol"},{"issue":"3","key":"7664_CR20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mus.22329","volume":"45","author":"EJ Cupler","year":"2012","unstructured":"Cupler EJ, Berger KI, Leshner RT, Wolfe GI, Han JJ, Barohn RJ, Kissel JT (2012) AANEM consensus committee on late-onset\u00a0Pompe\u00a0disease. Consensus treatment recommendations for late-onset\u00a0Pompe\u00a0disease. Muscle Nerve 45(3):319\u2013323","journal-title":"Muscle Nerve"},{"key":"7664_CR21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature04422","volume":"439","author":"D Gabellini","year":"2006","unstructured":"Gabellini D, D\u2019Antona G, Moggio M, Prelle A, Zecca C, Adami R, Angeletti B, Ciscato P, Pellegrino MA, Bottinelli R, Green MR, Tupler R (2006) Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature 439:973\u2013977","journal-title":"Nature"},{"issue":"1","key":"7664_CR22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00415-013-7137-2","volume":"261","author":"G Remiche","year":"2014","unstructured":"Remiche G, Ronchi D, Magri F, Lamperti C, Bordoni A, Moggio M, Bresolin N, Comi GP (2014) Extended phenotype description and new molecular findings in late onset glycogen storage disease type II: a northern\u00a0Italy population study and review of the literature. J Neurol 261(1):83\u201397","journal-title":"J Neurol"},{"issue":"7","key":"7664_CR23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1750-1172-7-88","volume":"12","author":"NA Beek Van der","year":"2012","unstructured":"Van der Beek NA, de Vries JM, Hagemans ML, Hop WC, Kroos MA, Wokke JH, de Visser M, van Engelen BG, Kuks JB, van der Kooi AJ, Notermans NC, Faber KG, Verschuuren JJ, Reuser AJ, van der Ploeg AT, van Doorn PA (2012) Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study. Orphanet J Rare Dis. 12(7):88","journal-title":"Orphanet J Rare Dis."},{"issue":"9\u201310","key":"7664_CR24","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.nmd.2007.06.002","volume":"17","author":"W M\u00fcller-Felber","year":"2007","unstructured":"M\u00fcller-Felber W, Horvath R, Gempel K, Podskarbi T, Shin Y, Pongratz D, Walter MC, Baethmann M, Schlotter-Weigel B, Lochm\u00fcller H, Schoser B (2007) Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Neuromuscul Disord 17(9\u201310):698\u2013706","journal-title":"Neuromuscul Disord"},{"key":"7664_CR25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1750-1172-7-73","volume":"7","author":"JM Vries de","year":"2012","unstructured":"de Vries JM, van der Beek NA, Hop WC, Karstens FP, Wokke JH, de Visser M, van Engelen BG, Kuks JB, van der Kooi AJ, Notermans NC, Faber CG, Verschuuren JJ, Kruijshaar ME, Reuser AJ, van Doorn PA, van der Ploeg AT (2012) Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study. Orphanet J Rare Dis 7:73","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"7664_CR26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0960-8966(00)00142-5","volume":"10","author":"S Tsujino","year":"2000","unstructured":"Tsujino S, Huie M, Kanazawa N, Sugie H, Goto Y, Kawai M, Nonaka I, Hirschhorn R, Sakuragawa N (2000) Frequent mutations in Japanese patients with acid maltase deficiency. Neuromuscul Disord 10(8):599\u2013603","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"7664_CR27","first-page":"67","volume":"26","author":"MG Pittis","year":"2007","unstructured":"Pittis MG, Filocamo M (2007) Molecular genetics of late onset glycogen storage disease II in Italy. Acta Myol 26(1):67\u201371","journal-title":"Acta Myol"},{"issue":"2","key":"7664_CR28","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/nar\/gkt987","volume":"42","author":"A Dardis","year":"2014","unstructured":"Dardis A, Zanin I, Zampieri S, Stuani C, Pianta A, Romanello M, Baralle FE, Bembi B, Buratti E (2014) Functional characterization of the common c.\u221232\u221213T>G mutation of GAA gene: identification of potential therapeutic agents. Nucleic Acids Res 42(2):1291\u20131302","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"7664_CR29","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/3.12.2231","volume":"3","author":"ML Huie","year":"1994","unstructured":"Huie ML, Chen AS, Tsujino S, Shanske S, DiMauro S, Engel AG, Hirschhorn R (1994) Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (\u221213T\u2192G) mutation in a majority of patients and a novel IVS10 (+1GT\u2192CT) mutation. Hum Mol Genet 3(12):2231\u20132236","journal-title":"Hum Mol Genet"},{"key":"7664_CR30","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1212\/WNL.57.5.906","volume":"57","author":"C Martini","year":"2001","unstructured":"Martini C, Ciana G, Benettoni A et al (2001) Intractable fever and cortical neuronal glycogen storage in glycogenosis type 2. Neurology 57:906\u2013908","journal-title":"Neurology"},{"key":"7664_CR31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00687878","volume":"23","author":"JJ Martin","year":"1973","unstructured":"Martin JJ, de Barsy T, Van Hoof F et al (1973) Pompe\u2019s disease: an inborn lysosomal disorder with storage of glycogen. Acta Neuropathol 23:229\u2013244","journal-title":"Acta Neuropathol"},{"key":"7664_CR32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00005072-196501000-00008","volume":"24","author":"EL Mancall","year":"1965","unstructured":"Mancall EL, Aponte GE, Berry RG (1965) Pompe\u2019s disease (diffuse glycogenosis) with neuronal storage. J Neuropathol Exp Neurol 24:85\u201396","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"7664_CR33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.5812\/ijem.4967","volume":"10","author":"G Papadimas","year":"2012","unstructured":"Papadimas G, Terzis G, Papadopoulos C, Areovimata A, Spengos K, Kavouras S, Manta P (2012) Bone density in patients with late onset\u00a0Pompe\u00a0disease. Int J Endocrinol Metab 10(4):599\u2013603","journal-title":"Int J Endocrinol Metab"},{"issue":"10","key":"7664_CR34","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s00415-010-5618-0","volume":"257","author":"S Sacconi","year":"2010","unstructured":"Sacconi S, Bocquet JD, Chanalet S, Tanant V, Salviati L, Desnuelle C (2010) Abnormalities of cerebral arteries are frequent in patients with late-onset\u00a0Pompe\u00a0disease. J Neurol 257(10):1730\u20131733","journal-title":"J Neurol"},{"issue":"5","key":"7664_CR35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000013628","volume":"20","author":"C Oktenli","year":"2000","unstructured":"Oktenli C (2000) Renal magnesium wasting, hypomagnesemic hypocalcemia, hypocalciuria and osteopenia in a patient withglycogenosis\u00a0type II. Am J Nephrol 20(5):412\u2013417","journal-title":"Am J Nephrol"},{"issue":"2\u20133","key":"7664_CR36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ymgme.2010.06.003","volume":"101","author":"DL Bernstein","year":"2010","unstructured":"Bernstein DL, Bialer MG, Mehta L, Desnick RJ (2010) Pompe\u00a0disease: dramatic improvement in gastrointestinal function following enzyme replacement therapy. A report of three later-onset patients. Mol Genet Metab 101(2\u20133):130\u2013133","journal-title":"Mol Genet Metab"},{"key":"7664_CR37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/8904_2014_334","volume":"17","author":"N Karabul","year":"2014","unstructured":"Karabul N, Skudlarek A, Berndt J, Kornblum C, Kley RA, Wenninger S, Tiling N, Mengel E, Pl\u00f6ckinger U, Vorgerd M, Deschauer M, Schoser B, Hanisch F (2014) Urge incontinence and gastrointestinal symptoms in adult patients with\u00a0Pompe disease: a cross-sectional survey. JIMD Rep 17:53\u201361","journal-title":"JIMD Rep"},{"issue":"3","key":"7664_CR38","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ymgme.2012.07.024","volume":"107","author":"O Musumeci","year":"2012","unstructured":"Musumeci O, Catalano N, Barca E, Ravaglia S, Fiumara A, Gangemi G, Rodolico C, Sorge G, Vita G, Galletti F, Toscano A (2012) Auditory system involvement in late onset Pompe\u00a0disease: a study of 20 Italian patients. Mol Genet Metab 107(3):480\u2013484","journal-title":"Mol Genet Metab"},{"issue":"2","key":"7664_CR39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10545-011-9396-3","volume":"35","author":"NA Beek Van der","year":"2012","unstructured":"Van der Beek NA, Verschuure H, Reuser AJ, van der Ploeg AT, van Doorn PA, Poublon RM (2012) Hearing in adults with\u00a0Pompe disease. J Inherit Metab Dis 35(2):335\u2013341","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"7664_CR40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000338776","volume":"68","author":"G Remiche","year":"2012","unstructured":"Remiche G, Herbaut AG, Ronchi D, Lamperti C, Magri F, Moggio M, Bresolin N, Comi GP (2012) Incontinence in late-onset\u00a0Pompe\u00a0disease: an underdiagnosed treatable condition. Eur Neurol 68(2):75\u201378","journal-title":"Eur Neurol"},{"issue":"2","key":"7664_CR41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10545-009-9027-4","volume":"33","author":"ML Hagemans","year":"2010","unstructured":"Hagemans ML, Stigter RL, van Capelle CI, van der Beek NA, Winkel LP, van Vliet L, Hop WC, Reuser AJ, Beishuizen A, van der Ploeg AT (2010) PAS-positive lymphocyte vacuoles can be used as diagnostic screening test for\u00a0Pompe\u00a0disease. J Inherit Metab Dis 33(2):133\u2013139","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"7664_CR42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1212\/01.wnl.0000270101.95790.fb","volume":"69","author":"S Ravaglia","year":"2007","unstructured":"Ravaglia S, Repetto A, De Filippi P, Danesino C (2007) Ptosis as a feature of late-onset glycogenosis type II. Neurology. 69(1):116","journal-title":"Neurology."},{"issue":"4","key":"7664_CR43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nmd.2012.12.003","volume":"23","author":"LD Hobson-Webb","year":"2013","unstructured":"Hobson-Webb LD, Jones HN, Kishnani PS (2013) Oropharyngeal dysphagia may occur in late-onset Pompe disease, implicating bulbar muscle involvement. Neuromuscul Disord 23(4):319\u2013322","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"7664_CR44","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3109\/14992027.2013.840932","volume":"52","author":"F Hanisch","year":"2013","unstructured":"Hanisch F, Rahne T, Plontke SK (2013) Prevalence of hearing loss in patients with late-onset\u00a0Pompe\u00a0disease: audiological and otological consequences. Int J Audiol 52(12):816\u2013823","journal-title":"Int J Audiol"},{"key":"7664_CR45","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10545-013-9601-7","volume":"36","author":"B Borroni","year":"2013","unstructured":"Borroni B, Cotelli MS, Premi E et al (2013) The brain in late-onset glycogenosis II: a structural and functional MRI study. J Inherit Metab Dis 36:989\u2013995","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"7664_CR46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1212\/WNL.0b013e31829a33ac","volume":"81","author":"MH Tsai","year":"2013","unstructured":"Tsai MH, Pardoe HR, Perchyonok Y, Fitt GJ, Scheffer IE, Jackson GD, Berkovic SF (2013) Etiology of hippocampal sclerosis: evidence for a predisposing familial morphologic anomaly. Neurology 81(2):144\u2013149","journal-title":"Neurology"},{"issue":"5","key":"7664_CR47","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/seiz.2001.0613","volume":"11","author":"SR Benbadis","year":"2002","unstructured":"Benbadis SR, Wallace J, Reed Murtagh F (2002) MRI evidence of mesial temporal sclerosis in subjects without\u00a0seizures. Seizure. 11(5):340\u2013343","journal-title":"Seizure."},{"issue":"2","key":"7664_CR48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1601-5215.2008.00273.x","volume":"20","author":"R Kumar","year":"2008","unstructured":"Kumar R, Sachdev PS, Price JL, Rosenman S, Christensen H (2008) Incidental brain MRI abnormalities in 60- to 64-year-old community-dwelling individuals: data from the Personality and Total Health Through Life study. Acta Neuropsychiatr. 20(2):87\u201390","journal-title":"Acta Neuropsychiatr."},{"issue":"9","key":"7664_CR49","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s00415-014-7402-z","volume":"261","author":"T Hundsberger","year":"2014","unstructured":"Hundsberger T, R\u00f6sler KM, Findling O (2014) Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis. J Neurol. 261(9):1684\u20131690","journal-title":"J Neurol."},{"issue":"6","key":"7664_CR50","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10545-014-9728-1","volume":"37","author":"LJ Anderson","year":"2014","unstructured":"Anderson LJ, Henley W, Wyatt KM, Nikolaou V, Waldek S, Hughes DA, Lachmann RH, Logan S (2014) Effectiveness of enzyme replacement therapy in adults with late-onset Pompe disease: results from the NCS-LSD cohort study. J Inherit Metab Dis. 37(6):945\u2013952","journal-title":"J Inherit Metab Dis."},{"issue":"8","key":"7664_CR51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1750-1172-8-49","volume":"27","author":"D G\u00fcng\u00f6r","year":"2013","unstructured":"G\u00fcng\u00f6r D, Kruijshaar ME, Plug I, D\u2019Agostino RB, Hagemans ML, van Doorn PA, Reuser AJ, van der Ploeg AT (2013) Impact of enzyme replacement therapy on survival in adults with\u00a0Pompe\u00a0disease: results from a prospective international observational study. Orphanet J Rare Dis. 27(8):49","journal-title":"Orphanet J Rare Dis."},{"issue":"7","key":"7664_CR52","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.nmd.2011.04.001","volume":"21","author":"D Orlikowski","year":"2011","unstructured":"Orlikowski D, Pellegrini N, Prigent H, Lafor\u00eat P, Carlier R, Carlier P, Eymard B, Lofaso F, Annane D (2011) Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to\u00a0Pompe\u00a0disease. Neuromuscul Disord 21(7):477\u2013482","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"7664_CR53","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00408-013-9489-x","volume":"191","author":"A Vianello","year":"2013","unstructured":"Vianello A, Semplicini C, Paladini L, Concas A, Ravaglia S, Servidei S, Toscano A, Mongini T, Angelini C, Pegoraro E (2013) Enzyme replacement therapy improves respiratory outcomes in patients with late-onset type II glycogenosis and high ventilator dependency. Lung 191(5):537\u2013544","journal-title":"Lung"},{"issue":"2","key":"7664_CR54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10545-011-9393-6","volume":"35","author":"Y Furusawa","year":"2012","unstructured":"Furusawa Y, Mori-Yoshimura M, Yamamoto T, Sakamoto C, Wakita M, Kobayashi Y, Fukumoto Y, Oya Y, Fukuda T, Sugie H, Hayashi YK, Nishino I, Nonaka I, Murata M (2012) Effects of enzyme replacement therapy on five patients with advanced late-onset glycogen storage disease type II: a 2-year follow-up study. J Inherit Metab Dis 35(2):301\u2013310","journal-title":"J Inherit Metab Dis"},{"issue":"1\u20132","key":"7664_CR55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10354-012-0153-5","volume":"163","author":"I Schneider","year":"2013","unstructured":"Schneider I, Hanisch F, M\u00fcller T, Schmidt B, Zierz S (2013) Respiratory function in late-onset\u00a0Pompe\u00a0disease patients receiving long-term enzyme replacement therapy for more than 48 months. Wien Med Wochenschr 163(1\u20132):40\u201344","journal-title":"Wien Med Wochenschr"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7664-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-015-7664-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7664-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T04:33:59Z","timestamp":1717734839000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-015-7664-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,12]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["7664"],"URL":"https:\/\/doi.org\/10.1007\/s00415-015-7664-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,12]]}}}